Companies / HXL
HEXIMA LIMITED.
ASX:HXLPharmaceuticals, Biotechnology & Life SciencesSuspended from quotation41.8M shares on issueASX (delayed) · as of 28 July 2026$0.013price · delayed—market cap · indicative
NR
Dilution grade
Not rated — the company is suspended from quotation
Cash runwayno data — suspended — grade not computed
Share-count growth (24m)no data — suspended — grade not computed
Raise cadence (24m)0 cash raises
Options & rights overhangno data
In-the-money supplyno data — no recent share price on record
Pending proposed issuesnone
HEXIMA LIMITED.'s share‑issuance history shows no Appendix 2A filings in the reporting window, so a share-count change figure is not available. The company did not raise capital in the 24‑month window. At the March 2026 quarter the company reported A$1.2M in available cash. No proposed securities issues (Appendix 3B) are pending.
AI-generated summary of this page's cited filings · updated 28 July 2026
0.0%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
17.4 qtrs
Cash cover · over 4 quarters
Shares on issue — last 2 years
Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 41.8M per ASX (delayed) (28 July 2026).
Cash runway
17.4 qtrs
More than four quarters of funding at the recent spend rate.
$1.2M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Join the waitlist
Issuance timeline
Latest 4 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 2 Apr 2025 | 3H · cancellation | HXL : ORDINARY FULLY PAID | 167.0M | Appendix 3H |
| 13 Jan 2025 | 3H · cancellation | HXL : ORDINARY FULLY PAID | 167.0M | Appendix 3H |
| 20 Mar 2024 | 3G · unquoted | HXL : ORDINARY FULLY PAID | 167.0M | Appendix 3G |
| 1 Feb 2024 | 3H · cancellation | HXL : ORDINARY FULLY PAID | 167.0M | Appendix 3H |
Paid plan
Full issuance history
Join the waitlist
Capital raises
No equity raises in the last 24 months.
Paid plan
Full raise history
Join the waitlist
Pending proposed issues
No proposed issues (Appendix 3B) currently pending.
Options & convertible securities
No options or rights over unissued shares on record.
Director dealings
No director dealing notices (Appendix 3Y) on record.
Paid plan
Full dealing history
Join the waitlist
Ownership
Free account
Top-20 holders & substantial holder notices
Sign up free — coming soon
Latest announcements
16 Apr 2026Update - Consolidation/Split - HXL
16 Apr 2026Results of Meeting
12 Mar 2026Consolidation/Split - HXL
12 Mar 2026Notification of cash return of capital
12 Mar 2026Notice of General Meeting and Proxy Form
27 Nov 2025AGM - Results of Meeting
24 Oct 2025Annual General Meeting & Proxy Form
18 Sept 2025Annual General Meeting & Director Nomination
29 Aug 2025Appendix 4G
29 Aug 20252025 Annual Report
14 Apr 2025Change of registry address notification
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.